The Ambassador Program: In a Nutshell
The landscape of clinical trials in PD research is hindered by significant recruitment challenges, with 85% of clinical trials facing delays due to under-enrollment¹, and 30% failing to recruit even a single participant². These statistics are particularly troubling in the context of Parkinson’s research, where only 10% of people with PD participate in research³, leading to a staggering 80% of studies failing to meet their recruitment targets⁴. Such under-enrollment results in profound missed opportunities for scientific advancement and the potential development of new therapies⁵.